| 摘要 |
The present invention provides a use of a L-phenylalanine conjugated to an alpha-, beta- or Auger-electron emitting isotope selected from the group consisting of bromine-76, bromine-77, bromine-82, iodine-124, iodine-125, iodine-131 and astatine-211 for the preparation of a pharmaceutical composition for the treatment of hormone dependent carcinoma and hormone-refractory or metastasized carcinoma derived from hormone dependent carcinoma. Furthermore, the invention provides an according method for the treatment of hormone dependent carcinoma and hormone-refractory or metastasized carcinoma derived from hormone dependent carcinoma and a method for the monitoring of the progress of such treatment. |
